Erratum: A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.